Navigation Links
Analysis Examines Ultrasound Use for Blood Clots
Date:2/2/2010

Review suggested one scan is usually enough, but editorial begs to differ

TUESDAY, Feb. 2 (HealthDay News) -- It's unusual for a paper in a medical journal to be accompanied by an editorial saying that the conclusion reported in the paper might be "overly simple and consequently not clinically useful."

However, that is exactly what has happened in the Feb. 3 issue of the Journal of the American Medical Association.

The paper in question, from researchers at the University of Utah, asks whether a single ultrasound exam might be enough to determine whether someone has a dangerous blood clot in a deep vein of a leg below the knee. The paper averaged the results of seven studies that included 4,731 cases, and concluded that the usual practice of doing repeat ultrasounds looking for such a deep vein thrombosis (DVT) isn't necessary.

The average risk of having a DVT in all the studies over the next three months was about one in 200, or 0.57 percent, such a low rate that the routine procedure of multiple ultrasound scans "requires further study," the report concluded, a polite way of saying that it isn't necessary.

But an accompanying editorial penned by two doctors who are consulting editors to the journal details serious doubts about that conclusion.

The reason for doubt, said editorial co-author Dr. Edward H. Livingston, who is chairman of gastrointestinal and endocrine surgery at the University of Texas Southwestern Medical Center in Dallas, is that the usual practice of lumping all the results of several studies together in a meta-analysis, and reasoning from the resulting average, doesn't work in this particular report.

One of the seven studies, which contributed nearly 25 percent of the total cases, included only ambulatory patients -- people who came to a doctor's office complaining of leg pain, Livingston said. That study, which found a thrombosis incidence of just 0.48 percent, pulled the overall results of the meta-analysis too far in one direction, he said.

Another study of 513 hospitalized people who had ultrasound exams for DVT found an incidence of 1.95 percent, the editorial noted. That four-times-higher incidence shows that the same criteria cannot be applied to both hospitalized and ambulatory patients, Livingston said.

The journal editors did a lot of talking before deciding that the paper should be run, he said. "We did a lot of analysis, looked at a lot of the literature," Livingston said. "Based on what I read, if you are ambulatory and have a low probability, with some leg pain, maybe a single ultrasound is good enough. The probability of having a DVT is low, and the test backs up your clinical suspicion. But a post-surgical or cancer patient who has a swollen leg, you would probably treat and look again, because the level of suspicion is high."

Treatment involves clot-preventing drugs, which carry their own danger of excess bleeding. The risk of such bleeding might be worth taking for someone in a hospital bed but not for an otherwise healthy person, Livingston said.

Beyond that, the lesson of the paper can be applied to all meta-analyses that lump together the results of different trials, he said. "It is a good platform to advise caution in judging all meta-analyses," Livingston said.

Averages derived by lumping many studies together can be deceptive, added editorial co-author Dr. Robert A. McNutt, a professor of medicine and chief of the section of patient safety research at Rush University Medical Center in Chicago.

"I prefer as a clinician to see the range of values across the studies rather than the average value of all the studies," McNutt said. "As a clinician, I look at the variability of patients, not the average value across the meta-analysis."

Controlled studies provide valuable evidence for medical practice, "but evidence-based medicine is not about the average patient but the nuances that clinicians have to deal with when managing individual patients," he said.

Attempts by HealthDay to reach the study authors for comment were unsuccessful.

More information

Learn about deep vein thrombosis from the U.S. National Heart, Lung, and Blood Institute.



SOURCES: Edward H. Livingston, M.D., professor and chairman, gastrointestinal and endocrine surgery, University of Texas Southwestern Medical Center, Dallas; Robert A. McNutt, M.D., professor, medicine, and chief, section of patient safety research, Rush University Medical Center, Chicago; Feb. 3, 2010, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. TGen analysis identifies biomarkers for diabetic kidney failure
2. Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015
3. Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
4. Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
5. Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources
7. Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)
8. InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software
9. New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums
10. Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
11. Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Swirl: A Wine Tasting Event in New York City, with long-time partners The ...
(Date:12/4/2016)... ... ... While James Earl Jones is known for myriad roles on stage and ... Page". One of the forthcoming episodes examines mammogram techniques; a very important part of ... due to early detection. Like any other disease, treatments have a much higher chance ...
(Date:12/4/2016)... , ... December 03, 2016 , ... ... growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual ... Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded ...
(Date:12/4/2016)... Newport Beach, CA (PRWEB) , ... December 04, ... ... youthful appearance without undergoing major cosmetic surgery can now take advantage of a ... is an advanced skin rejuvenation treatment that reduces the appearance of age spots, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... Blueprint Medicines Corporation (NASDAQ: BPMC ... kinase medicines for patients with genomically defined diseases, ... trial evaluating BLU-285, an investigational medicine for the ... Blueprint Medicines is developing BLU-285 as a potent, ... 90 to 95 percent of patients with SM ...
(Date:12/4/2016)... HANOVER, N.J. , Dec. 3, 2016  Results ... (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the median ... 45.3% compared to placebo (1.63 vs 2.98, p=0.010) in ... today announced that the data are being featured in ... American Society of Hematology (ASH) Annual Meeting and presented ...
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test para el mercado africano ... Continue Reading ... New: INSTI Self Test! (PRNewsFoto/bioLytical ... bioLytical Laboratories (la "Compañía"), un líder mundial en ... de su INSTI HIV Self Test  a África con una versión de menor ...
Breaking Medicine Technology: